Method for predicting the risk of developing a colonic neoplasia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9410955
APP PUB NO 20140186366A1
SERIAL NO

14123121

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an in vitro method for determining whether a patient having hyperplastic polyps is at risk of developing a colonic neoplasia after resection of said hyperplastic polyps, said method comprising the step of determining the level of progastrin expression in a tissue sample of a hyperplastic polyp obtained from said patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)PARIS FRANCE PARIS PARIS
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE2 RUE VIGUERIE HÔTEL-DIEU PONT NEUF TOULOUSE 31300
UNIVERSITE PAUL SABATIER - TOULOUSE III118 ROUTE DE NARBONNE TOULOUSE CEDEX 9 31062

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Delisle, Marie-Bernadette Toulouse, FR 1 1
Do, Catherine Toulouse, FR 1 1
Ferrand, Audrey Toulouse, FR 1 1
Palasse, Julien Toulouse, FR 1 1
Seva, Catherine Toulouse, FR 1 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 9, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00